Obtaining clear margins following a lumpectomy surgery for breast cancer is an important factor in the treatment of breast cancer while conserving the breast (BCS). Historically, high rates, 26%, of surgical interventions to obtain clear margins have been reported.
Publication of Data Demonstrating/2023/09/22/dilon-technologies-announces-the-publication-of-data-demonstrating-cost-savings-results-from-the-use-of-marginprobetm-compared-to-a-full-cavity-shave-fcs-approach
Dilon Technologies announced the publication of a study comparing cost minimization in breast-conserving surgery using radiofrequency spectroscopy with a full cavity shave approach.
The page lists clinicians and their affiliations, including the Reinsch Pierce Family Center for Breast Health, Virginia Hospital Center, Complete Breast Care, and the University of California Irvine.
Dilon Technologies is a women's healthcare company that has expanded into biosurgery and develops, manufactures, and promotes medical devices for healthcare providers. Its portfolio includes MarginProbe.